Desensitization of an adult patient with Pompe disease and a history of anaphylaxis to alglucosidase alfa

被引：23

作者：

Lipinski, Shawn E. ^{[1
]}

Lipinski, Michael J. ^{[2
]}

Burnette, Autumn ^{[3
]}

Platts-Mills, Thomas A. ^{[3
]}

Wilson, William G. ^{[1
]}

机构：

[1] Univ Virginia Hlth Syst, Dept Pediat, Div Med Genet, Charlottesville, VA 22908 USA

[2] Univ Virginia Hlth Syst, Dept Internal Med, Charlottesville, VA 22908 USA

[3] Univ Virginia Hlth Syst, Asthma & Allerg Dis Ctr, Charlottesville, VA 22908 USA

来源：

MOLECULAR GENETICS AND METABOLISM | 2009年 / 98卷 / 03期

关键词：

Pompe disease; Enzyme replacement therapy; Lysosomal storage disease; Anaphylaxis; Allergy;

D O I：

10.1016/j.ymgme.2009.07.001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We report on the successful desensitization of an adult female with Pompe disease who had previously experienced anaphylaxis to intravenous alglucosidase alfa therapy. The starting alglucosidase alfa dose for desensitization was 10 mg/kg with gradual dose escalation and desensitization via serial dilution was completed over five infusions. This methodology serves as a means to desensitize patients with prior anaphylactic response to alglucosidase alfa so that enzyme replacement therapy can be utilized. (C) 2009 Elsevier Inc. All rights reserved.

引用

页码：319 / 321

页数：3

共 50 条

[11] A phase 4 prospective study in patients with adult Pompe disease treated with alglucosidase alfa
Thurberg, Beth L.
Carlier, Pierre
Kissel, John T.
Schoser, Benedikt
Pestronk, Alan
Barohn, Richard
Goker-Alpan, Ozlem
Mozaffar, Tahseen
Pena, Loren D. M.
Simmons, Zachary
Straub, Volker
Young, Peter
Shafi, Raheel
Bjartmar, Carl
van der Ploeg, Ans
[J]. MOLECULAR GENETICS AND METABOLISM, 2015, 114 (02) : S113 - S114
[12] Severe sleep apnea associated with adult onset Pompe disease: Improvement with alglucosidase alfa
Kiyan, E.
Engin-Unver, R.
Deymeer, F.
Parman, Y.
Serdaroglu-Oflazer, P.
[J]. NEUROMUSCULAR DISORDERS, 2009, 19 (8-9) : 593 - 594
[13] Desensitization of two young patients with infantile-onset Pompe disease and severe reactions to alglucosidase alfa
Gragnaniello, V.
Fecarotta, S.
Pecoraro, A.
Tarallo, A.
Catzola, A.
Spadaro, G.
Parenti, G.
Della Casa, R.
[J]. NEUROLOGICAL SCIENCES, 2019, 40 (07) : 1453 - 1455
[14] Desensitization of two young patients with infantile-onset Pompe disease and severe reactions to alglucosidase alfa
V. Gragnaniello
S. Fecarotta
A. Pecoraro
A. Tarallo
A. Catzola
G. Spadaro
G. Parenti
R. Della Casa
[J]. Neurological Sciences, 2019, 40 : 1453 - 1455
[15] Cessation and resuming of alglucosidase alfa in Pompe disease: a retrospective analysis
Thomas Hundsberger
Kai M. Rösler
Oliver Findling
[J]. Journal of Neurology, 2014, 261 : 1684 - 1690
[16] Alglucosidase alfa in infants and children with advanced pompe disease.
Kishnani, P.
Byrne, B.
Hwu, W. -L.
Leslie, N.
Mandel, H.
Wraith, J.
Nicolino, M.
[J]. MOLECULAR GENETICS AND METABOLISM, 2008, 93 (03) : 254 - 254
[17] Safety and efficacy of alternative alglucosidase alfa regimens in Pompe disease
Case, Laura E.
Bjartmar, Carl
Morgan, Claire
Casey, Robin
Charrow, Joel
Clancy, John P.
Dasouki, Majed
DeArmey, Stephanie
Nedd, Khan
Nevins, Mary
Peters, Heidi
Phillips, Dawn
Spigelman, Zachary
Tifft, Cynthia
Kishnani, Priya S.
[J]. NEUROMUSCULAR DISORDERS, 2015, 25 (04) : 321 - 332
[18] Cessation and resuming of alglucosidase alfa in Pompe disease: a retrospective analysis
Hundsberger, Thomas
Roesler, Kai M.
Findling, Oliver
[J]. JOURNAL OF NEUROLOGY, 2014, 261 (09) : 1684 - 1690
[19] Alglucosidase alfa therapy for Pompe disease in pregnancy - Case report
Klos, Justyna
Kwasniak-Butowska, Magdalena
Slawek, Jaroslaw
[J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 375 : 167 - 169
[20] Pompe Disease Treatment success with Alglucosidase alfa in the late form of the disease
Ecker-Schlipf, Barbara
[J]. PSYCHOPHARMAKOTHERAPIE, 2010, 17 (05): : 255 - 256

← 1 2 3 4 5 →